American Well (NYSE:AMWL – Free Report) had its price target decreased by Morgan Stanley from $20.00 to $10.50 in a report released on Tuesday,Benzinga reports. Morgan Stanley currently has an equal weight rating on the stock.
Separately, Needham & Company LLC reiterated a “hold” rating on shares of American Well in a research report on Thursday, October 31st.
Check Out Our Latest Analysis on American Well
American Well Price Performance
Hedge Funds Weigh In On American Well
Hedge funds have recently modified their holdings of the company. BNP Paribas Financial Markets bought a new stake in shares of American Well in the third quarter worth about $95,000. PDT Partners LLC bought a new stake in shares of American Well in the 3rd quarter worth approximately $107,000. Walleye Capital LLC purchased a new position in shares of American Well during the third quarter valued at approximately $167,000. HighTower Advisors LLC bought a new position in shares of American Well during the third quarter valued at approximately $355,000. Finally, Rock Point Advisors LLC lifted its stake in American Well by 1.9% in the second quarter. Rock Point Advisors LLC now owns 2,308,617 shares of the company’s stock worth $750,000 after acquiring an additional 43,500 shares during the period. Hedge funds and other institutional investors own 56.05% of the company’s stock.
American Well Company Profile
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.
Recommended Stories
- Five stocks we like better than American Well
- The 3 Best Blue-Chip Stocks to Buy Now
- AppLovin Insiders Sell Shares: Stock Price Indicated Higher
- Election Stocks: How Elections Affect the Stock Market
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- Overbought Stocks Explained: Should You Trade Them?
- Salesforce’s Clear Path to $400 and Beyond
Receive News & Ratings for American Well Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Well and related companies with MarketBeat.com's FREE daily email newsletter.